Variables | Periprocedural Myocardial Injury | p value | |
---|---|---|---|
No (n = 81) | Yes (n = 48) | ||
Age (years) | 68.7 ± 9.7 | 69.3 ± 10.1 | 0.75 |
Male, n (%) | 69 (85.2) | 38 (79.2) | 0.38 |
Body mass index (kg/m2) | 23.7 (21.9–26.7) | 24.2 (22.4–25.9) | 0.95 |
Current smoking, n (%) | 15 (18.5) | 13 (27.1) | 0.25 |
Hypertension, n (%) | 63 (77.8) | 35 (72.9) | 0.53 |
Diabetes mellitus, n (%) | 39 (48.1) | 20 (41.7) | 0.48 |
Dyslipidemia, n (%) | 62 (76.5) | 35 (72.9) | 0.65 |
Prior myocardial infarction, n (%) | 20 (24.7) | 18 (37.5) | 0.10 |
eGFR (mL/min/1.73 m2) | 69.0 (58.3–77.6) | 65.1 (55.6–76.4) | 0.37 |
Total cholesterol (mg/dL) | 158 (139–180) | 157 (125–186) | 0.81 |
LDL cholesterol (mg/dL) | 89 (74–106) | 93 (70–113) | 0.76 |
HDL cholesterol (mg/dL) | 44.6 ± 10.3 | 41.0 ± 10.0 | 0.049 |
HDL2 cholesterol (mg/dL) | 25.0 ± 6.8 | 23.5 ± 7.4 | 0.26 |
HDL3 cholesterol (mg/dL) | 16.4 ± 2.9 | 15.1 ± 3.0 | 0.016 |
Triglycerides (mg/dL) | 113 (85–163) | 119 (93–156) | 0.46 |
Hemoglobin A1c (%) | 6.4 (5.9–6.9) | 6.1 (5.7–6.7) | 0.11 |
C-reactive protein (mg/L) | 1.2 (0.5–3.4) | 1.7 (0.8–4.3) | 0.25 |
ACE-I or ARB, n (%) | 54 (63.0) | 28 (65.1) | 0.34 |
Beta-blocker, n (%) | 30 (37.0) | 21 (48.8) | 0.45 |
Calcium channel blocker, n (%) | 28 (34.6) | 19 (39.6) | 0.57 |
Anti-diabetes drugs, n (%) | 28 (34.6) | 13 (27.1) | 0.38 |
Statin, n (%) | 67 (82.7) | 40 (83.3) | 0.93 |
Eicosapentaenoic acid, n (%) | 6 (7.4) | 5 (10.4) | 0.55 |
Ezetimibe, n (%) | 2 (2.5) | 2 (4.2) | 0.59 |